Craft

Medtronic

Stock Price

$79.9

2024-06-17

Market Capitalization

$107.6 B

2024-06-15

Revenue

$31.2 B

FY, 2023

Medtronic Summary

Company Summary

Overview
Medtronic is a company that specializes in healthcare technologies and therapies. It operates through four segments: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes implantable devices, leads, and delivery systems, products for the treatment of atrial fibrillation, devices for the repair and replacement of heart valves, coronary stents, and other products. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, airway, ventilation, inhalation therapy products, etc. The Neuroscience Portfolio segment provides platform technologies, implant therapies, biologic solutions, pelvic health and neurovascular products, and other solutions. The Diabetes Operating Unit segment delivers insulin pumps and consumables, continuous glucose monitoring systems and sensors, infusion sets, etc.
Type
Public
Status
Active
Founded
1949
HQ
Dublin, IE | view all locations
Website
https://www.medtronic.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Geoff Martha
  • Karen L. Parkhill

    Karen L. Parkhill, EVP & Chief Financial Officer

  • Torod Neptune

    Torod Neptune, SVP & Chief Communications Officer

  • Ivan K. Fong

    Ivan K. Fong, EVP, General Counsel & Secretary

Operating MetricsView all

Countries

150

FY, 2023

Floor Space, square feet

9.8M
2.1%

FY, 2023

Patients

74M
2.6%

FY, 2023

LocationsView all

120 locations detected

  • Dublin, D HQ

    Ireland

    20 On Hatch, Lower Hatch Street

  • Boulder, CO

    United States

    6135 Gunbarrel Ave

  • Columbia Heights, MN

    United States

    800 53rd Ave NE

  • Danvers, MA

    United States

    35 Cherry Hill Dr

  • Doral, FL

    United States

    9850 NW 41st St #450

  • Eatontown, NJ

    United States

    51 James Way

and 114 others

Medtronic Financials

Summary Financials

Revenue (Q3, 2024)
$8.1B
Gross profit (Q3, 2024)
$5.3B
Net income (Q3, 2024)
$1.3B
Cash (Q3, 2024)
$1.6B
EBIT (Q3, 2024)
$1.5B
Enterprise value
$131.2B

Footer menu